(Q50553420)

15 March 2018

title

Infectivity of HBV DNA positive donations identified in look-back studies in Hyogo-Prefecture, Japan (English)

1 reference

15 March 2018

1 reference

Y Bouike

1

1 reference

15 March 2018

S Imoto

2

1 reference

15 March 2018

O Mabuchi

3

1 reference

15 March 2018

A Kokubunji

4

1 reference

15 March 2018

S Kai

5

1 reference

15 March 2018

M Okada

6

1 reference

15 March 2018

R Taniguchi

7

1 reference

15 March 2018

S Momose

8

1 reference

15 March 2018

S Uchida

9

1 reference

15 March 2018

H Nishio

10

1 reference

15 March 2018

publication date

30 November 2010

1 reference

15 March 2018

published in

Transfusion Medicine

1 reference

15 March 2018

volume

21

1 reference

15 March 2018

issue

2

1 reference

15 March 2018

page(s)

107-115

1 reference

15 March 2018

Hepatitis B virus blood screening: unfinished agendas

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2010.01057.X

Hepatitis B virus traceback and lookback: factors to consider

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2010.01057.X

Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2010.01057.X

High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2010.01057.X

Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2010.01057.X

Transfusion medicine illustrated. Japanese repositories.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2010.01057.X

Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2010.01057.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2010.01057.X

A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2010.01057.X

HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2010.01057.X

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2010.01057.X

Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2010.01057.X

Long-term histologic and virologic outcomes of acute self-limited hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3148.2010.01057.X

10.1111/J.1365-3148.2010.01057.X

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018